Why is Gland Pharma falling/rising?

As of 24-Sep, Gland Pharma Ltd's stock price is currently at 1,980.45, reflecting a decrease of 37.35 points, or 1.85%. The stock has underperformed its sector today by 1.4%, reaching an intraday low of Rs 1968.95, which is a decline of 2.42%. Over the past week, the stock has seen a slight decrease of 0.33%, but it has performed positively over the past month with an increase of 1.53%. Year-to-date, Gland Pharma has outperformed the market with a return of 10.73% compared to the Sensex's 4.58%. Despite a strong performance in the recent quarterly results, including record net sales and significant growth in profit before tax, the stock is experiencing a decline, which may be attributed to falling investor participation, as evidenced by a 38.89% drop in delivery volume against the 5-day average.
In the broader market context, Gland Pharma's recent performance contrasts with the benchmark, as it has generated a positive return of 6.71% over the past year while the Sensex has declined by 3.77%. This indicates that despite the current price drop, the stock has been resilient compared to the overall market. The company's low debt-to-equity ratio and high institutional holdings suggest a stable financial position, which could provide some support against the recent price decline. However, the stock's current underperformance today and reduced trading volume may indicate a cautious sentiment among investors, potentially impacting its short-term outlook.